Diagnostyka S.A. (WSE:DIA)
Poland · Delayed Price · Currency is PLN 163.90
-2.20 (-1.32%)
At close: Jul 24, 2026
Diagnostyka Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,500 | 2,424 | 1,975 | 1,597 | 1,436 | 1,843 | |
Revenue Growth (YoY) | 21.30% | 22.77% | 23.65% | 11.25% | -22.10% | - |
Cost of Revenue | 1,375 | 923.1 | 763.14 | 1,176 | 1,031 | 1,021 |
Gross Profit | 1,125 | 1,501 | 1,212 | 421.34 | 404.18 | 821.96 |
Depreciation & Amortization Expenses | 211.28 | 201.79 | 161.53 | 147.25 | 125.86 | 113.84 |
Other Operating Expenses | 55.65 | 59.81 | 41.38 | 39.83 | 44.03 | 25.46 |
Total Operating Expenses | 266.92 | 261.61 | 202.91 | 187.08 | 169.89 | 139.3 |
Operating Income | 393.54 | 382.7 | 338.01 | 234.26 | 242.94 | 687.84 |
Interest Income | 4.16 | 3.04 | 10.55 | 2.58 | 21.7 | 36.21 |
Interest Expense | -69.87 | -68.86 | -57.37 | -58.28 | -32.87 | -24.13 |
Other Non-Operating Income (Expense) | - | - | - | -4.94 | -9.92 | - |
Total Non-Operating Income (Expense) | -65.71 | -65.82 | -46.82 | -60.64 | -21.09 | 12.08 |
Pretax Income | 327.83 | 316.88 | 291.19 | 173.62 | 221.85 | 699.91 |
Provision for Income Taxes | 55.14 | 55.01 | 59.24 | 43.63 | 50.19 | 137.48 |
Net Income | 272.69 | 261.87 | 231.96 | 129.99 | 171.66 | 562.43 |
Minority Interest in Earnings | 11.39 | 10.27 | 8.63 | 6.56 | 4.25 | 4.64 |
Net Income to Common | 261.3 | 251.6 | 223.33 | 123.43 | 167.42 | 557.79 |
Net Income Growth | 12.65% | 12.66% | 80.93% | -26.27% | -69.99% | - |
Shares Outstanding (Basic) | 34 | 34 | 34 | 34 | 34 | 34 |
Shares Outstanding (Diluted) | 34 | 34 | 34 | 34 | 34 | 34 |
Shares Change (YoY) | - | - | - | - | - | - |
EPS (Basic) | 7.74 | 7.45 | 6.62 | 3.66 | 4.96 | 16.52 |
EPS (Diluted) | 7.74 | 7.45 | 6.62 | 3.66 | 4.96 | 16.52 |
EPS Growth | 12.50% | 12.54% | 80.87% | -26.21% | -69.98% | - |
Free Cash Flow | 357.42 | 346.99 | 282.72 | 254.66 | 184.5 | 606.94 |
Free Cash Flow Growth | 12.97% | 22.73% | 11.02% | 38.03% | -69.60% | - |
Free Cash Flow Per Share | 10.59 | 10.28 | 8.38 | 7.54 | 5.47 | 17.98 |
Dividends Per Share | 4.400 | 4.400 | 3.310 | - | - | - |
Dividend Growth | 32.93% | 32.93% | - | - | - | - |
Gross Margin | 45.00% | 61.92% | 61.35% | 26.38% | 28.15% | 44.60% |
Operating Margin | 15.74% | 15.79% | 17.12% | 14.67% | 16.92% | 37.33% |
Profit Margin | 10.91% | 10.80% | 11.75% | 8.14% | 11.96% | 30.52% |
FCF Margin | 14.30% | 14.31% | 14.32% | 15.95% | 12.85% | 32.94% |
EBITDA | 604.81 | 584.5 | 499.54 | 381.51 | 356.68 | 801.68 |
EBITDA Margin | 24.19% | 24.11% | 25.30% | 23.89% | 24.85% | 43.50% |
EBIT | 393.54 | 382.7 | 338.01 | 234.26 | 242.94 | 687.84 |
EBIT Margin | 15.74% | 15.79% | 17.12% | 14.67% | 16.92% | 37.33% |
Effective Tax Rate | 16.82% | 17.36% | 20.34% | 25.13% | 22.62% | 19.64% |